Dynavax Technologies Corp (NASDAQ:DVAX)

16.40
Delayed Data
As of 3:57pm ET
 +0.30 / +1.86%
Today’s Change
5.35
Today|||52-Week Range
24.45
-12.30%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close16.10
Today’s open16.15
Day’s range16.11 - 16.45
Volume799,165
Average volume (3 months)1,627,978
Market cap$1.2B
Data as of 3:57pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+38.01%
Earnings growth (this year)-35.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.04%
P/E ratioNM
Price/Sales3,008.76
Price/Book6.15

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA-0.27-0.88%
XNCRXencor Inc+0.08+0.21%
DERMDermira Inc-2.38-22.66%
AIMTAimmune Therapeutics...+0.38+1.17%
Data as of 3:57pm ET, 05/24/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$327.0K
Annual profit (last year)-$95.2M
Net profit margin-29,099.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts